These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35175159)

  • 1. Usefulness of complete blood count parameters to predict poor outcomes in cancer patients with febrile neutropenia presenting to the emergency department.
    Choi A; Park I; Lee HS; Chung J; Kim MJ; Park YS
    Ann Med; 2022 Dec; 54(1):599-609. PubMed ID: 35175159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive performance of the quick Sequential Organ Failure Assessment score as a screening tool for sepsis, mortality, and intensive care unit admission in patients with febrile neutropenia.
    Kim M; Ahn S; Kim WY; Sohn CH; Seo DW; Lee YS; Lim KS
    Support Care Cancer; 2017 May; 25(5):1557-1562. PubMed ID: 28062972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Serum Procalcitonin Levels in Patients With Febrile Neutropenia Presenting to the Emergency Department.
    Yadav S; Mathew R; Sahu AK; Jamshed N; Mohindra R; Aggarwal P; Batra A; Halder D; Brunda RL
    J Emerg Med; 2021 May; 60(5):641-647. PubMed ID: 33518374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the relationship between mortality and SOFA, qSOFA, MASCC scores in febrile neutropenic patients monitored in the intensive care unit.
    Cetintepe T; Cetintepe L; Solmaz S; Calık S; Ugur MC; Gediz F; Bilgir O
    Support Care Cancer; 2021 Jul; 29(7):4089-4094. PubMed ID: 33404806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents.
    Ahn S; Rice TW; Yeung SJ; Cooksley T
    Support Care Cancer; 2018 May; 26(5):1465-1470. PubMed ID: 29168032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of procalcitonin and lipopolysaccharide binding protein in cancer patients with chemotherapy-associated febrile neutropenia presenting to an emergency department.
    García de Guadiana-Romualdo L; Cerezuela-Fuentes P; Español-Morales I; Esteban-Torrella P; Jiménez-Santos E; Hernando-Holgado A; Albaladejo-Otón MD
    Biochem Med (Zagreb); 2019 Feb; 29(1):010702. PubMed ID: 30591812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Febrile neutropenia in patients with acute myeloid leukemia: Outcome in relation to qSOFA score, C-reactive protein, and blood culture findings.
    Lappalainen M; Hämäläinen S; Romppanen T; Pulkki K; Pyörälä M; Koivula I; Jantunen E; Juutilainen A
    Eur J Haematol; 2020 Dec; 105(6):731-740. PubMed ID: 32740997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department.
    Coyne CJ; Le V; Brennan JJ; Castillo EM; Shatsky RA; Ferran K; Brodine S; Vilke GM
    Ann Emerg Med; 2017 Jun; 69(6):755-764. PubMed ID: 28041827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and predictors of poor outcome in children with febrile neutropaenia presenting to the emergency department.
    Long E; Babl FE; Phillips N; Craig S; Zhang M; Kochar A; McCaskill M; Borland ML; Slavin MA; Phillips R; Lourenco RA; Michinaud F; Thursky KA; Haeusler G;
    Emerg Med Australas; 2022 Oct; 34(5):786-793. PubMed ID: 35419955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergency Ambulatory Management of Low-Risk Febrile Neutropenia: Multinational Association for Supportive Care in Cancer Fits-Real-World Experience From a UK Cancer Center.
    Marshall W; Campbell G; Knight T; Al-Sayed T; Cooksley T
    J Emerg Med; 2020 Mar; 58(3):444-448. PubMed ID: 31744709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Factors Predicting Poor Outcome in Cancer Patients with Febrile Neutropenia in the Emergency Department: Usefulness of qSOFA.
    Lee SJ; Kim JH; Han SB; Paik JH; Durey A
    J Oncol; 2018; 2018():2183179. PubMed ID: 30405714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of an inflammatory biomarker-based clinical algorithm in septic patients in the emergency department: An observational study.
    Zhao C; Wei Y; Chen D; Jin J; Chen H
    Int Immunopharmacol; 2020 Mar; 80():106145. PubMed ID: 31955067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent factors for prediction of poor outcomes in patients with febrile neutropenia.
    Günalp M; Koyunoğlu M; Gürler S; Koca A; Yeşilkaya I; Öner E; Akkaş M; Metin Aksu N; Demirkan A; Polat O; Elhan AH
    Med Sci Monit; 2014 Oct; 20():1826-32. PubMed ID: 25282155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study.
    Carmona-Bayonas A; Jiménez-Fonseca P; Virizuela Echaburu J; Antonio M; Font C; Biosca M; Ramchandani A; Martínez J; Hernando Cubero J; Espinosa J; Martínez de Castro E; Ghanem I; Beato C; Blasco A; Garrido M; Bonilla Y; Mondéjar R; Arcusa Lanza MÁ; Aragón Manrique I; Manzano A; Sevillano E; Castañón E; Cardona M; Gallardo Martín E; Pérez Armillas Q; Sánchez Lasheras F; Ayala de la Peña F
    J Clin Oncol; 2015 Feb; 33(5):465-71. PubMed ID: 25559804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction and validation of a nomogram for predicting the prognosis of patients with septic shock in department of emergency medicine].
    Wang T; Li J; Hao D; Qi A
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Jun; 36(6):578-584. PubMed ID: 38991955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic performance of adding patient-reported outcomes to the MASCC risk index to identify low-risk febrile neutropenia patients with solid tumors and lymphomas.
    Wang XJ; Goh DYT; Dorajoo SR; Chan A
    Support Care Cancer; 2017 Sep; 25(9):2815-2822. PubMed ID: 28401314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can MASCC and CISNE scores predict delays of lung cancer chemotherapy after febrile neutropenia?
    Ono Y; Hayama N; Hattori S; Ito Y; Oguma T; Sakamaki F; Asano K
    Thorac Cancer; 2022 Dec; 13(24):3504-3509. PubMed ID: 36330990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of the quick sequential organ failure assessment for predicting clinical outcomes among community-acquired pneumonia patients presenting in the emergency department.
    Zhang X; Liu B; Liu Y; Ma L; Zeng H
    BMC Infect Dis; 2020 Apr; 20(1):316. PubMed ID: 32349682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergency department management of chemotherapy related febrile neutropenia: An opportunity to improve care.
    Pettit N; Boadu D; Bischof JJ
    Am J Emerg Med; 2021 Dec; 50():5-9. PubMed ID: 34265732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department.
    Peyrony O; Gerlier C; Barla I; Ellouze S; Legay L; Azoulay E; Chevret S; Fontaine JP
    PLoS One; 2020; 15(2):e0229828. PubMed ID: 32109264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.